Scientists from Tel Aviv University believe they have made a breakthrough that could help treat Alzheimer’s disease, the university said Wednesday.
Researchers lead by Professor Daniel M. Michaelson managed to change the nature of the APOE gene in mice, which has been associated with the debilitating, neuro-degenerative disease.
The gene has a healthy form called APOE3 and a disease-related form APOE4, which is found in 60 percent of sufferers.
“Researchers have developed a novel mechanism and approach with which to convert the “bad” APOE4 to the “good” APOE3,” a statement from the university said.
The results of the study, which was jointly conducted by the university and the commercial company Artery Ltd., based in California, was published last month in the Journal of Alzheimer’s Disease.
Get The Times of Israel's Daily Edition
by email and never miss our top stories
By signing up, you agree to the
terms
“APOE4 is a very important and understudied target,” Michaelson said, but noted that this was only one dimension of attempts to find a cure for the disease. “Is there really a magic bullet? One treatment that covers all aspects of Alzheimer’s? Not likely,” he said.
The researchers found in the course of administering treatment that mice, which prior to the treatment exhibited disoriented behavior and seemed lost, were able following treatment to locate a submerged island in the middle of an artificial pond.
Your next read: ToI Editors' Picks
LIMITED TIME OFFER: Join The Times of Israel Community today and you'll receive a physical book of your choice, carefully curated by our editors.
Choose between two must-reads: When We See You Again by Rachel Goldberg-Polin, a searing portrait of a mother’s grief and strength following unthinkable tragedy;
Or Out of the Sky: Heroism and Rebirth in Nazi Europe by Matti Friedman, the gripping and surprising tale of a forgotten moment during World War II.
As a Community member, you’ll also enjoy our DocuNation series of outstanding Israeli documentary films, an ad-free experience of our site and podcasts, commenting privileges, and more.
CHOOSE YOUR BOOK
CHOOSE YOUR BOOK
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this